Bhatt,Deepak L

Institution: Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany

Top Collaborators: , Steg PG, Cannon CP, Montalescot G, Fonarow GC, Goto S, Hernandez AF, Peterson ED, Alberts MJ, Topol EJ, Schwamm LH, Bavry AA, Smith SC, Steinhubl SR, Brennan DM, Hirsch AT, Bangalore S, Berger PB, Eagle KA, Wolski K

Research Interests: Patients, Risk, Disease, Syndromes, Platelet, Aspirin, Acute Coronary Syndromes, Treatment, Infarction, Myocardial Infarction, Artery, Role, Inhibition, Mortality, Coronary Artery, Coronary Artery Disease, Drug-eluting Stents, Stents, Thrombin, Adenosine

Publications

Information and abstracts for author publications
Published Date	Impact	Publication
12/16/2009	53.3	The New England journal of medicine Platelet inhibition with cangrelor in patients undergoing PCI.	Abstract
03/26/2012	53.3	The New England journal of medicine Bariatric surgery versus intensive medical therapy in obese patients with diabetes.	Abstract
03/18/2009	16.7	Annals of internal medicine Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding.	Abstract
06/01/2010	14.7	Circulation Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.	Abstract
09/07/2010	14.7	Circulation Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries.	Abstract
04/18/2011	14.7	Circulation Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial.	Abstract
08/30/2010	14.7	Circulation Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) Registry.	Abstract
11/23/2009	14.7	Circulation Smoking, clopidogrel, and mortality in patients with established cardiovascular disease.	Abstract
08/03/2009	14.7	Circulation Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program.	Abstract
05/09/2013	14.2	Journal of the American College of Cardiology Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.	Abstract
11/05/2012	14.2	Journal of the American College of Cardiology Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction.	Abstract
08/21/2009	10.5	European heart journal Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study.	Abstract
01/09/2009	10.5	European heart journal Patients with peripheral arterial disease in the CHARISMA trial.	Abstract
07/12/2011	8.8	Nature reviews. Cardiology The evolution of antiplatelet therapy in cardiovascular disease.	Abstract
02/25/2013	8.1	Diabetes care Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment.	Abstract
10/11/2010	7.6	Archives of neurology Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials.	Abstract
11/25/2013	7.1	International journal of cardiology Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry.	Abstract
07/15/2010	6.8	JACC. Cardiovascular interventions The state of periprocedural antiplatelet therapy after recent trials.	Abstract
06/19/2012	5.7	Stroke; a journal of cerebral circulation Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.	Abstract
06/02/2009	5.4	The American journal of medicine Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up.	Abstract
07/02/2009	5	Thrombosis and haemostasis The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.	Abstract
02/06/2012	4.7	American heart journal Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.	Abstract
05/21/2012	4.7	American heart journal Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial.	Abstract
11/08/2011	4.7	American heart journal Regional differences in clinical profile, quality of care, and outcomes among Hispanic patients hospitalized with acute myocardial infarction in the Get with Guidelines-Coronary Artery Disease (GWTG-CAD) registry.	Abstract
12/04/2009	4.7	American heart journal Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry.	Abstract
03/10/2011	4.2	Heart (British Cardiac Society) High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial.	Abstract
06/29/2011	4.2	Heart (British Cardiac Society) Risk factors and outcomes for patients with vascular disease and serious bleeding events.	Abstract
08/30/2012	3.8	Atherosclerosis Endothelial progenitor cell response to antiproliferative drug exposure.	Abstract
01/24/2012	3.8	Atherosclerosis Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes.	Abstract
02/03/2010	3.8	Cleveland Clinic journal of medicine Controversies in non-ST-elevation acute coronary syndromes and percutaneous coronary interventions.	Abstract
02/03/2010	3.8	Cleveland Clinic journal of medicine Omeprazole and clopidogrel: Should clinicians be worried?	Abstract
04/26/2010	3.4	Diabetes, obesity & metabolism Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE).	Abstract
01/26/2009	3.4	The American journal of cardiology Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.	Abstract
01/19/2011	3.4	The American journal of cardiology Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.	Abstract
01/12/2009	3.4	The American journal of cardiology Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator.	Abstract
09/02/2010	3	Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy Role of dual antiplatelet therapy in symptomatic patients with established vascular disease: putting the CHARISMA trial into therapeutic perspective.	Abstract
02/15/2010	2.6	Current problems in cardiology Antiplatelet agents in acute coronary syndromes.	Abstract
05/18/2011	2.6	Current problems in cardiology Anticoagulant agents in acute coronary syndromes.	Abstract
10/18/2012	2.3	Current opinion in cardiology Antiplatelet therapy and proton pump inhibition: cause for concern?	Abstract
07/03/2012	2.2	Clinical cardiology Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelines.	Abstract
07/03/2012	2.2	Clinical cardiology Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus.	Abstract
09/24/2013	2.2	Clinical cardiology Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: findings from Get With the Guidelines-Coronary Artery Disease.	Abstract